Psychedelic Drugs Market To Grow By $1.37 bn From 2024-2028
Report with market evolution powered by AI- The global psychedelic drugs market size is estimated to grow by USD 1.37 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 11.82% during the forecast period. Rising prevalence of mental health disorders is driving market growth. With a trend towards increasing focus of vendors on developing next-generation therapies for psychiatric disorders. However, side effects associated with psychedelic drugs poses a challenge. Key market players include AbbVie Inc., ATAI LIFE SCIENCES N.V, Avadel Pharmaceuticals plc, Braxia Scientific Corp., COMPASS Pathways plc, Cybin Inc., HAVN Life Sciences Inc, Jazz Pharmaceuticals Plc, Johnson and Johnson Services Inc., Lykos Therapeutics, Mind Medicine Inc., Pfizer Inc., Seelos Therapeutics Inc., Silo Pharma Inc., and Stella.
Key Market Trends Fueling Growth
The Psychedelic Drugs Market refers to the production, distribution, and sale of psychedelic substances. Such as LSD and psilocybin, for therapeutic and recreational use. Key players in this market include companies focused on the research. Development of psychedelic drugs for medical applications, as well as those involved in the production and sale of these substances for recreational use. The market size is expected to grow due to increasing research and development efforts in the field of psychedelic therapy, as well as shifting regulatory attitudes towards these substances. Companies are investing in clinical trials and product development to meet the growing demand for psychedelic therapies. The market is also driven by the rising awareness of the potential benefits of psychedelics in treating mental health conditions, such as depression and PTSD. However, regulatory challenges and ethical concerns remain significant barriers to market growth.
Market Challenges
The Psychedelic Drugs Market refers to the production, distribution, and sale of psychedelic substances, such as LSD and magic mushrooms. Key players in this market include Mydecine Innovations Group, Compass Pathways, and MindMed. These companies focus on researching and developing psychedelic-based therapies for mental health conditions, such as depression and PTSD. The market is expected to grow due to increasing awareness and acceptance of psychedelic therapies. As well as ongoing clinical trials. However, regulatory challenges and potential safety concerns remain.
Research Analysis
Psychedelic drugs, including Ketamine, Psilocybin mushrooms, LSD, and Gamma-Hydroxybutyric Acid (GHB), are naturally occurring or synthetic substances known for their hallucinogenic effects. These psychoactive compounds have gained renewed interest in recent years due to their potential therapeutic applications in various mental health disorders. Psychedelics have shown promise in treating conditions such as Narcolepsy, Treatment-Resistant Depression, Major Depressive Disorder, Opiate Addiction, and Post-Traumatic Stress Disorder. They have also been explored for pain disorders, sleep-related disorders, and trauma. Despite their therapeutic potential, these psychoactive substances remain largely illegal or restricted as Schedule I drugs in many parts of the world.
Market Research Overview
Psychedelic drugs, including Ketamine, Psilocybin mushrooms, LSD, and Gamma-Hydroxybutyric Acid (GHB), represent a growing market for the treatment of various mental health disorders and pain management. These substances can be found in both synthetic and natural forms. Indications for psychedelic drugs include Narcolepsy, Treatment-Resistant Depression, Major Depressive Disorder, Opiate Addiction, and Post-Traumatic Stress Disorder. They are administered through various routes such as Hospitals, Specialty Clinics, Homecare, and Pharmacies (Hospitals, Retail, and Online). The use of psychedelic substances for therapeutic purposes is a controversial topic. Due to cultural norms, conservative values, and religious beliefs.
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends. This provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage. Extensive research, and actionable market insights to identify opportunities in existing. Potential markets and assess their competitive positions within changing market scenarios.
Disclaimer: The above content is originally posted on prnewswire.com. We have reposted the article. The relevant information is provided by Technavio. All credit goes to their respective Copy Right Holders. ( Technavio )
Source Link: www.prnewswire.com
